You Snooze, You Lose: Tips To Stay On Top Of Impending Wave Of EU Regulatory Change
This article was originally published in Clinica
Executive Summary
All manufacturers will need to review their product portfolios to determine which products will remain on the market in Europe under the new Medical Device Regulation. The next step will be to prioritize which of these products should be brought under compliance with the MDR first, then ensure timely assessments by notified bodies.
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.